|
Delayed
Australian S.E.
22:27:18 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.3350 AUD | +15.52% |
|
+26.42% | -48.46% |
| Market Cap | 88.67M 61.92M 55.2M 51.13M 46.49M 87.24M 5.87B 613M 241M 3.07B 232M 227M 9.81B | P/E 2027 * |
-3.41x | P/E 2028 * | 2.61x |
|---|---|---|---|---|---|
| Enterprise Value | 114M 79.36M 70.74M 65.53M 59.58M 112M 7.52B 786M 309M 3.93B 298M 292M 12.57B | EV / Sales 2027 * |
9.09x | EV / Sales 2028 * | 0.75x |
| Free-Float |
62.73% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| RCE | Delayed | |
Deutsche Boerse AG
| R9Q | Delayed | |
|
Börse Stuttgart
| R9Q | Delayed | |
|
Boerse Muenchen
| R9Q | Real-time | |
|
Tradegate
| R9Q | Real-time |
| 1 day | +15.52% | ||
| 1 week | +26.42% | ||
| Current month | +6.35% | ||
| 1 month | -1.47% | ||
| 3 months | -6.94% | ||
| 6 months | -36.79% | ||
| Current year | -48.46% |
| 1 week | 0.27 |  | 0.34 |
| 1 month | 0.26 | | 0.34 |
| Current year | 0.26 | | 0.73 |
| 1 year | 0.26 | | 0.73 |
| 3 years | 0.26 | | 0.73 |
| 5 years | 0.26 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 2020-08-27 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 2020-09-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 2012-09-30 |
James Graham
BRD | Director/Board Member | - | 2012-04-30 |
| Director/Board Member | - | 2022-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/31/26 | Buy | Chief Executive Officer | 25,000 | 0.0083% | ||
| 7/31/26 | Buy | Director | 75,000 | 0.0250% | ||
| 7/31/26 | Buy | Director | 37,500 | 0.0125% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +15.52% | +26.42% | -16.25% | -25.56% | 61.7M | |
| -1.33% | +4.88% | +54.50% | +109.94% | 1,120B | |
| -0.69% | -3.77% | +31.35% | +66.62% | 616B | |
| -0.96% | +0.55% | +23.13% | +94.26% | 504B | |
| +0.24% | +5.58% | +33.98% | +59.40% | 367B | |
| -1.59% | -1.25% | +69.39% | +43.02% | 360B | |
| -0.40% | +3.53% | +19.17% | +46.55% | 288B | |
| -0.37% | +3.11% | -1.26% | +18.23% | 258B | |
| -1.75% | +1.76% | +42.21% | +51.44% | 234B | |
| -2.00% | +1.75% | +24.64% | +95.14% | 194B | |
| Average | +0.67% | +1.90% | +28.09% | +55.90% | 394.1B | |
| Weighted average by Cap. | -0.99% | +2.42% | +37.89% | +75.52% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 12.5M 8.73M 7.78M 7.21M 6.55M 12.29M 827M 86.42M 33.98M 432M 32.74M 32.05M 1.38B | 54.3M 37.92M 33.8M 31.31M 28.47M 53.42M 3.6B 376M 148M 1.88B 142M 139M 6.01B |
| Net income | -25.1M -17.53M -15.62M -14.47M -13.16M -24.69M -1.66B -174M -68.26M -869M -65.76M -64.38M -2.78B | 33.4M 23.32M 20.79M 19.26M 17.51M 32.86M 2.21B 231M 90.84M 1.16B 87.51M 85.68M 3.69B |
| Net Debt | 24.96M 17.43M 15.54M 14.39M 13.09M 24.56M 1.65B 173M 67.89M 864M 65.41M 64.04M 2.76B | -48.1M -33.59M -29.94M -27.74M -25.22M -47.32M -3.18B -333M -131M -1.66B -126M -123M -5.32B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-19 | A$0.3350 | +15.52% | 541,234 |
| 26-10-19 | A$0.2900 | 0.00% | 93,370 |
| 26-10-16 | A$0.2900 | +3.57% | 86,627 |
| 26-10-15 | A$0.2800 | -3.45% | 15,301 |
| 26-10-14 | A$0.2900 | +9.43% | 43,027 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
